Skip to main content
Top
Published in: Journal of Gastroenterology 5/2017

01-05-2017 | Original Article—Alimentary Tract

Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease

Authors: Jordi Rimola, Almudena Alvarez-Cofiño, Tamara Pérez-Jeldres, Carmen Ayuso, Ignacio Alfaro, Sonia Rodríguez, Elena Ricart, Ingrid Ordás, Julián Panés

Published in: Journal of Gastroenterology | Issue 5/2017

Login to get access

Abstract

Background

Magnetic resonance enterography (MRE) is an accurate examination for assessing activity in Crohn’s disease (CD). Various MRE indices have been developed for that purpose, but have not been directly compared. The aim of the study was to compare the diagnostic accuracy of three MRE indices for detecting and grading disease activity in CD, using endoscopy as gold standard.

Methods

MRE and ileocolonoscopies performed within 1 month in 43 patients with CD were analyzed. The magnetic resonance index of activity (MaRIA), Clermont, and London indices for each colonic segment and the terminal ileum were calculated. Simplified endoscopy score for CD (SES-CD) was considered the gold standard.

Results

Two hundred and twenty-four intestinal segments were included in the analysis. According to the established cut-off points for detecting active disease using MaRIA, Clermont, and London indices, the sensitivity of each index was 0.88, 0.89, and 0.71, and the specificity was 0.97, 0.78, and 0.99, respectively. The sensitivity for detecting ulcerations was 0.90 and 0.83 for the MaRIA and Clermont indices, respectively, with a specificity of 0.91 and 0.89. The AUROC curve for the MaRIA, Clermont, and London indices for detecting active disease was 0.92, 0.84, and 0.85, and for detecting ulcerations was 0.90 for the MaRIA, and 0.86 for Clermont index.

Conclusions

The three MRE-based indices evaluated in the current study have high diagnostic accuracy for assessment of disease activity. The MaRIA index has the best operational characteristics for detecting not only disease activity but also for grading severity, which supports its use in clinical studies and clinical practice.
Appendix
Available only for authorised users
Literature
2.
go back to reference Coimbra AJF, Rimola J, O’Byrne S, et al. Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn’s disease, and may help select subjects with active inflammation. Aliment Pharmacol Ther. 2016;43:61–72.CrossRefPubMed Coimbra AJF, Rimola J, O’Byrne S, et al. Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn’s disease, and may help select subjects with active inflammation. Aliment Pharmacol Ther. 2016;43:61–72.CrossRefPubMed
4.
go back to reference Rimola J, Ordás I, Rodríguez S, et al. Imaging indexes of activity and severity for Crohn’s disease: current status and future trends. Abdom Imaging. 2012;37:958–66.CrossRefPubMed Rimola J, Ordás I, Rodríguez S, et al. Imaging indexes of activity and severity for Crohn’s disease: current status and future trends. Abdom Imaging. 2012;37:958–66.CrossRefPubMed
5.
go back to reference Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–20.CrossRefPubMed Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–20.CrossRefPubMed
7.
go back to reference Steward MJ, Punwani S, Proctor I, et al. Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol. 2012;81:2080–8.CrossRefPubMed Steward MJ, Punwani S, Proctor I, et al. Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol. 2012;81:2080–8.CrossRefPubMed
8.
go back to reference Hordonneau C, Buisson A, Scanzi J, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol. 2014;109:89–98. doi:10.1038/ajg.2013.385.CrossRefPubMed Hordonneau C, Buisson A, Scanzi J, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol. 2014;109:89–98. doi:10.​1038/​ajg.​2013.​385.CrossRefPubMed
10.
go back to reference Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.CrossRefPubMed Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.CrossRefPubMed
11.
go back to reference Buisson A, Hordonneau C, Goutte M, et al. Diffusion-weighted magnetic resonance entero-colonography is highly effective to detect ileocolonic endoscopic ulcerations in Crohn’s disease. Aliment Pharmacol Ther. 2015;42:452–60. doi:10.1111/apt.13287.CrossRefPubMed Buisson A, Hordonneau C, Goutte M, et al. Diffusion-weighted magnetic resonance entero-colonography is highly effective to detect ileocolonic endoscopic ulcerations in Crohn’s disease. Aliment Pharmacol Ther. 2015;42:452–60. doi:10.​1111/​apt.​13287.CrossRefPubMed
12.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
13.
go back to reference Bleeker SE, Moll HA, Steyerberg EW, et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003;56:826–32.CrossRefPubMed Bleeker SE, Moll HA, Steyerberg EW, et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003;56:826–32.CrossRefPubMed
14.
go back to reference Takenaka K, Ohtsuka K, Kitazume Y, et al. Comparison of magnetic resonance and balloon enteroscopic disease. Gastroenterology. 2014;147:334–42.CrossRefPubMed Takenaka K, Ohtsuka K, Kitazume Y, et al. Comparison of magnetic resonance and balloon enteroscopic disease. Gastroenterology. 2014;147:334–42.CrossRefPubMed
15.
go back to reference Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn’ s disease of the terminal ileum 1. Acad Radiol. 2008;15:153–64.CrossRefPubMed Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn’ s disease of the terminal ileum 1. Acad Radiol. 2008;15:153–64.CrossRefPubMed
16.
go back to reference Hyun SB, Kitazume Y, Nagahori M, et al. Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn’s disease. Inflamm Bowel Dis. 2011;17:1063–72. doi:10.1002/ibd.21510.CrossRefPubMed Hyun SB, Kitazume Y, Nagahori M, et al. Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn’s disease. Inflamm Bowel Dis. 2011;17:1063–72. doi:10.​1002/​ibd.​21510.CrossRefPubMed
17.
go back to reference Makanyanga JC, Pendsé D, Dikaios N, et al. Evaluation of Crohn’ s disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol. 2014;24:277–87.CrossRefPubMed Makanyanga JC, Pendsé D, Dikaios N, et al. Evaluation of Crohn’ s disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol. 2014;24:277–87.CrossRefPubMed
18.
go back to reference Higgins PDR, Caoili E, Zimmermann M, et al. Computed tomographic enterography adds information to clinical management in small bowel Crohn’s disease. Inflamm Bowel Dis. 2007;13:262–8. doi:10.1002/ibd.20013.CrossRefPubMed Higgins PDR, Caoili E, Zimmermann M, et al. Computed tomographic enterography adds information to clinical management in small bowel Crohn’s disease. Inflamm Bowel Dis. 2007;13:262–8. doi:10.​1002/​ibd.​20013.CrossRefPubMed
19.
go back to reference García-Bosch O, Ordás I, Aceituno M, et al. Comparison of diagnostic accuracy and impact of MRI and colonoscopy for the management of Crohn’s disease. J Crohns Colitis. 2016;. doi:10.1093/ecco-jcc/jjw015.PubMed García-Bosch O, Ordás I, Aceituno M, et al. Comparison of diagnostic accuracy and impact of MRI and colonoscopy for the management of Crohn’s disease. J Crohns Colitis. 2016;. doi:10.​1093/​ecco-jcc/​jjw015.PubMed
20.
go back to reference Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–55.CrossRefPubMedPubMedCentral Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–55.CrossRefPubMedPubMedCentral
22.
go back to reference Seo N, Park SH, Kim KJ, Kang BK, Lee Y, Ye BD, Park SH, et al. MR enterography for the evaluation of small-bowel Inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study. Radiology. 2016;278:762–72.CrossRefPubMed Seo N, Park SH, Kim KJ, Kang BK, Lee Y, Ye BD, Park SH, et al. MR enterography for the evaluation of small-bowel Inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study. Radiology. 2016;278:762–72.CrossRefPubMed
Metadata
Title
Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease
Authors
Jordi Rimola
Almudena Alvarez-Cofiño
Tamara Pérez-Jeldres
Carmen Ayuso
Ignacio Alfaro
Sonia Rodríguez
Elena Ricart
Ingrid Ordás
Julián Panés
Publication date
01-05-2017
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 5/2017
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1253-6

Other articles of this Issue 5/2017

Journal of Gastroenterology 5/2017 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Autoimmune hepatitis in Japan: trends in a nationwide survey

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.